Bernard Duclos

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Marc Lémann, Jean–Yves Mary, Bernard Duclos et al. · Gastroenterology · 2006 · 372 citations

Pharmacy, Immunology, Pharmacotherapy +12

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

Laurent Beaugerie, Magali Svrcek, Philippe Seksik et al. · Gastroenterology · 2013 · 360 citations · Full text

Medicine, Oncology, Pathology +16

A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine

Marc Lémann, Jean–Yves Mary, Jean‐Frédéric Colombel et al. · Gastroenterology · 2005 · 351 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.

J.M. Reimund, C Wittersheim, Serge Dumont et al. · Gut · 1996 · 301 citations · Full text

Medicine, Immunology, Pathology +17